These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 18803476)

  • 21. Cancer screening over 65.
    Bishop KD
    Med Health R I; 2009 Feb; 92(2):61-2. PubMed ID: 19288688
    [No Abstract]   [Full Text] [Related]  

  • 22. Avoiding verification bias in screening test evaluation in resource poor settings: a case study from Zimbabwe.
    Gaffikin L; McGrath J; Arbyn M; Blumenthal PD
    Clin Trials; 2008; 5(5):496-503. PubMed ID: 18827042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Race and the validity of self-reported cancer screening behaviors: development of a conceptual model.
    Burgess DJ; Powell AA; Griffin JM; Partin MR
    Prev Med; 2009 Feb; 48(2):99-107. PubMed ID: 19118570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostate cancer early detection clinical practice guidelines in oncology.
    Babaian RJ; Partin AW;
    J Natl Compr Canc Netw; 2003 Jan; 1 Suppl 1():S42-55. PubMed ID: 19795575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early warnings.
    Nature; 2009 Apr; 458(7239):679. PubMed ID: 19360033
    [No Abstract]   [Full Text] [Related]  

  • 26. Training in the primary prevention and early detection of oral cancer: pilot study of its impact on clinicians' perceptions and intentions.
    LeHew CW; Epstein JB; Koerber A; Kaste LM
    Ear Nose Throat J; 2009 Jan; 88(1):748-53. PubMed ID: 19172574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer screening in the United States, 2009: a review of current American Cancer Society guidelines and issues in cancer screening.
    Smith RA; Cokkinides V; Brawley OW
    CA Cancer J Clin; 2009; 59(1):27-41. PubMed ID: 19147867
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies should be controlled, randomized, and blinded.
    Parker RA
    Clin Pharmacol Ther; 2009 May; 85(5):461-3. PubMed ID: 19381148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Examination of external validity in randomized controlled trials for adjuvant treatment of pancreatic adenocarcinoma.
    Sorg C; Schmidt J; Büchler MW; Edler L; Märten A
    Pancreas; 2009 Jul; 38(5):542-50. PubMed ID: 19287330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostate cancer screening: the continuing controversy.
    Wilbur J
    Am Fam Physician; 2008 Dec; 78(12):1377-84. PubMed ID: 19119557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PSA-based screening for localised prostate cancer. Uncertain benefits, potential adverse consequences, and many outstanding questions.
    Prescrire Int; 2009 Oct; 18(103):225. PubMed ID: 19882799
    [No Abstract]   [Full Text] [Related]  

  • 32. Bowel cancer screening--a role for general practice.
    Foreman L
    Aust Fam Physician; 2009 Apr; 38(4):200-3. PubMed ID: 19350068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Indications and timing for prostate biopsy, diagnosis of early stage prostate cancer and its definitive treatment: a clinical conundrum in the PSA era.
    Punnen S; Nam RK
    Surg Oncol; 2009 Sep; 18(3):192-9. PubMed ID: 19282170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methods in cancer epigenetics and epidemiology.
    Kumar D; Verma M
    Methods Mol Biol; 2009; 471():273-88. PubMed ID: 19109785
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Challenges in evaluating influenza vaccine effectiveness and the mortality benefits controversy.
    Nichol KL
    Vaccine; 2009 Oct; 27(45):6305-11. PubMed ID: 19840665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The haphazard approach to the early detection of asymptomatic renal cancer: results from a contemporary executive health programme.
    Feldstein MS; Rhodes DJ; Parker AS; Orford RR; Castle EP
    BJU Int; 2009 Jul; 104(1):53-6. PubMed ID: 19154476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Population-based screening for colorectal cancer: Australian research and implementation.
    Young GP
    J Gastroenterol Hepatol; 2009 Oct; 24 Suppl 3():S33-42. PubMed ID: 19799696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Guideline implementation for breast healthcare in low- and middle-income countries: early detection resource allocation.
    Yip CH; Smith RA; Anderson BO; Miller AB; Thomas DB; Ang ES; Caffarella RS; Corbex M; Kreps GL; McTiernan A;
    Cancer; 2008 Oct; 113(8 Suppl):2244-56. PubMed ID: 18837017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of satisfaction with cancer screening at mobile van and static sites: National Cancer Screening Program in Korea.
    Yoon NH; Lee HY; Kwak MS; Choi KS; Jun JK; Kim MK; Park EC
    Jpn J Clin Oncol; 2009 Mar; 39(3):169-74. PubMed ID: 19179364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostate-specific antigen kinetics in localized and advanced prostate cancer.
    Fitzpatrick JM; Banu E; Oudard S
    BJU Int; 2009 Mar; 103(5):578-87. PubMed ID: 19210674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.